[ÀÇ·á°è ¼Ò½Ä] °í´ë¾È¾Ïº´¿ø ±³¼öÆÀ, ¹é½Å ¸é¿ª¹ÝÀÀ ¹àÇô ´ëÇÑÁø´Ü¸é¿ªÇÐȸ ¿ì¼ö¿¬Á¦»ó ¼ö»ó

ÀÔ·Â 2022.05.18 14:23
°í·Á´ë ¾È¾Ïº´¿ø Áø´Ü°Ë»çÀÇÇаú Á¶À±Á¤, ³²¹ÎÁ¤ ±³¼ö
°í·Á´ë ¾È¾Ïº´¿ø Áø´Ü°Ë»çÀÇÇаú Á¶À±Á¤, ³²¹ÎÁ¤ ±³¼ö./»çÁø=°í·Á´ë ¾È¾Ïº´¿ø

°í·Á´ë ¾È¾Ïº´¿ø Áø´Ü°Ë»çÀÇÇаú Á¶À±Á¤, ³²¹ÎÁ¤ ±³¼ö°¡ Áö³­´Þ 27ÀÏ °³ÃÖµÈ ¡®2022 ´ëÇÑÁø´Ü¸é¿ªÇÐȸ Ãá°èÇмú´ëȸ¡¯¿¡¼­ '¿ì¼ö¿¬Á¦»ó'À» ¼ö»óÇß´Ù.

Á¶À±Á¤ ±³¼ö¿Í ³²¹ÎÁ¤ ±³¼ö´Â Äڷγª(SARS-CoV-2) ¹ÙÀÌ·¯½º¿¡ ´ëÇÑ º¤Å͹é½Å, È¥ÇÕ¹é½Å, mRNA ¹é½Å Á¢Á¾±º¿¡¼­ ü¾×¼º ¹× ¼¼Æ÷¼º ¸é¿ª¹ÝÀÀ¿¡ ¹ÌÄ¡´Â ¿äÀÎ(Factors Affecting Humoral and Cellular Immune Responses to Vector, Mix-and-match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses)À» ±Ô¸íÇØ À̹ø ¼ö»óÀÇ ÁÖÀΰøÀÌ µÆ´Ù.

Á¶À±Á¤ ±³¼ö´Â ¡°´Ü±â°£ ³»¿¡ ¼¼°èÀû À¯ÇàÀ» ÃÊ·¡ÇÑ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ¿¡ ´ëÇØ ¹ü±¹°¡ÀûÀ¸·Î ½Å¼ÓÇÏ°Ô ¿¹¹æ ¹× Ä¡·áÀü·«À» ±¸ÃàÇÏ¿© ½ÇÇàÇß´ø °Íó·³ ÇâÈÄ ¹é½Å Á¢Á¾ÀÚ¿¡¼­ÀÇ µ¹ÆÄ°¨¿°¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀο¡ ´ëÇÑ Ãß°¡ ºÐ¼®À» ÁøÇàÇÒ ¿¹Á¤"À̶ó¸ç "±× ¿¬±¸°á°ú°¡ ÇâÈÄ ½ÅÁ¾Àü¿°º´¿¡ ´ëÇÑ ¹é½ÅÁ¤Ã¥ ¼ö¸³¿¡ Áß¿äÇÑ ±âÃÊÀÚ·á°¡ µÉ °Í"À̶ó°í Çß´Ù.

ÀÌ ±â»ç¿Í °ü·Ã±â»ç